A breakthrough treatment for Alzheimer's Disease is being rationed by the federal government, despite clearance by the FDA. Lindsey Golden, Advocacy Manager for the Alzheimer's Association - North Carolina, has details on a rally in Charlotte to call for the Centers for Medicare and Medicaid Services to cover lecanemab without barriers.
Get exclusive content here!: https://thepetekalinershow.com/
See omnystudio.com/listener for privacy information.